133 related articles for article (PubMed ID: 6757861)
21. [Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history].
Nos P; Argüello L; Hoyos M; Ramírez JJ; Hinojosa J; Molés JR; García A; Berenguer M; Berenguer J
Rev Esp Enferm Dig; 1996 Jul; 88(7):470-4. PubMed ID: 8924324
[TBL] [Abstract][Full Text] [Related]
22. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
[TBL] [Abstract][Full Text] [Related]
23. Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study.
Riegler G; Caserta L; Castiglione F; Esposito I; Valpiani D; Annese V; Zoli G; Gionchetti P; Viscido A; Sturniolo GC; Rispo A; De Filippo FR; de Leone A; Carratu R;
Dig Liver Dis; 2006 Jan; 38(1):18-23. PubMed ID: 16169781
[TBL] [Abstract][Full Text] [Related]
24. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
Agius LM
J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody 1F10 immunoreactivity in inflammatory bowel disease: a new marker specific only for continuous endothelial cells.
Lügering N; Stoll R; Holzgreve A; Winde G; Sorg C; Domschke W
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):777-81. PubMed ID: 7496869
[TBL] [Abstract][Full Text] [Related]
27. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
[TBL] [Abstract][Full Text] [Related]
28. Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis?
Asakura H; Suzuki K; Kitahora T; Morizane T
J Gastroenterol Hepatol; 2008 Dec; 23(12):1794-801. PubMed ID: 19120872
[TBL] [Abstract][Full Text] [Related]
29. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
Kull K; Salupere R; Uibo R; Ots M; Salupere V
Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
[TBL] [Abstract][Full Text] [Related]
30. Environmental risk factors in inflammatory bowel disease.
Koutroubakis I; Manousos ON; Meuwissen SG; Pena AS
Hepatogastroenterology; 1996; 43(8):381-93. PubMed ID: 8714231
[TBL] [Abstract][Full Text] [Related]
31. Epidemiological aspects of inflammatory bowel disease in the Pamplona area.
Arin Letamendia A; Burusco Paternain MJ; Borda Celaya F; Pueyo Royo A; Martínez Echeverría A; Jiménez Pérez FJ
Rev Esp Enferm Dig; 1999 Nov; 91(11):769-76. PubMed ID: 10601770
[TBL] [Abstract][Full Text] [Related]
32. [Incidence and prevalence of inflammatory bowel disease in Gijon, Asturias, Spain].
Saro Gismera C; Lacort Fernández M; Argüelles Fernández G; Antón Magarzo J; García López R; Navascues CA; Suárez González A; Díaz Alvarez G; González Bernal A; Palacios Galán A; Altadill Arregui A; Vizoso F
Gastroenterol Hepatol; 2000; 23(7):322-7. PubMed ID: 11002532
[TBL] [Abstract][Full Text] [Related]
33. [Polymorphism of the microsatellites and tumor necrosis factor genes in chronic inflammatory bowel diseases].
Heresbach D; Ababou A; Bourienne A; Alizadeh M; Quelvennec E; Pagenault M; Dabadie A; Berre NH; Campion JP; Launois B; Gosselin M; Genetet B; Bretagne JF; Semana G
Gastroenterol Clin Biol; 1997; 21(8-9):555-61. PubMed ID: 9587492
[TBL] [Abstract][Full Text] [Related]
34. [Epidemiology in inflammatory bowel disease in five areas of Asturias. Spain].
Saro Gismera C; Riestra Menéndez S; Sánchez Fernández R; Milla Crespo A; Lacort Fernández M; Argüelles Fernández G; Chobak Z; Florido Mancheño JI; Antón Magarzo JL; Altadill Arregui A; Vizoso F; Pineda García E; Fernández de Ocariz Archs E; Albert Colomer J; García Pérez J; López Rivas L; Lombraña JL
An Med Interna; 2003 May; 20(5):232-8. PubMed ID: 12831296
[TBL] [Abstract][Full Text] [Related]
35. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
Brand S
Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of inflammatory bowel disease.
Lashner BA
Gastroenterol Clin North Am; 1995 Sep; 24(3):467-74. PubMed ID: 8809231
[TBL] [Abstract][Full Text] [Related]
37. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
[TBL] [Abstract][Full Text] [Related]
38. [New developments in Crohn's disease: unravelling the mystery of its etiopathogenesis and its reinstatement as a surgically treatable condition. Part 3: The rational principles of surgical therapy].
Tonelli P
Chir Ital; 2000; 52(4):335-42. PubMed ID: 11190523
[TBL] [Abstract][Full Text] [Related]
39. Psoriasis associated with ulcerative colitis and Crohn's disease.
Cohen AD; Dreiher J; Birkenfeld S
J Eur Acad Dermatol Venereol; 2009 May; 23(5):561-5. PubMed ID: 19207663
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of Crohn's disease in Israel: a survey of Israeli kibbutz settlements.
Niv Y; Abuksis G; Fraser GM
Am J Gastroenterol; 1999 Oct; 94(10):2961-5. PubMed ID: 10520852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
